Endometriosis causes deleterious effects on the lives of sufferers across multiple domains impacting quality of life. Commonly utilized pharmaceutical interventions offer suboptimal efficacy in addition to potentially intolerable side effects for many women. There is some evidence for dietary therapies reducing endometriosis symptoms, but little data on dietary preferences/strategies used, and their impact, in a community setting.
Methods:
A cross-sectional online survey was conducted between October and December 2017 to investigate the self-management strategies employed by women with endometriosis. Participants were aged 18–45 years, living in Australia, and had a surgically confirmed diagnosis of endometriosis.
Results:
Four hundred eighty-four responses were included for analysis, with 76% of women reporting the use of general self-management strategies within the last 6 months. Of these, 44% of respondents reported using dietary strategies for symptom management. Reducing or eliminating gluten, reducing or eliminating dairy, and the low-fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet were the most commonly reported dietary strategies utilized. Respondents reported a 6.4/10 effectiveness score for reduction in pelvic pain with dietary changes, with no difference in pain reduction between the various diets used. Furthermore, women self-reported significant improvements in comorbidities such as gastrointestinal (GI) disturbance (39%), nausea and vomiting (15%), and fatigue (15%).
Conclusions:
Dietary modifications are a very common self-management strategy employed by people with endometriosis, with the greatest benefit reported on GI symptoms. Reducing or eliminating gluten, dairy, or FODMAPs or a combination of these was the most common strategy. No single diet appeared to provide greater self-reported benefits than others.
JohnsonNP, HummelshojL, AdamsonGD, et al.World Endometriosis Society consensus on the classification of endometriosis. Hum Reprod, 2017; 32:315–324.
3.
ViganoP, ParazziniF, SomiglianaE, VercelliniP. Endometriosis: Epidemiology and aetiological factors. Best Pract Res Clin Obstet Gynaecol, 2004; 18:177–200.
4.
VosT, BarberRM, BellB, et al.Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet, 2015; 386:743–800.
5.
ZondervanKT, BeckerCM, MissmerSA. Endometriosis. N Engl J Med, 2020; 382:1244–1256.
6.
Ramin-WrightA, SchwartzASK, GeraedtsK, et al.Fatigue—A symptom in endometriosis. Hum Reprod, 2018; 33:1459–1465.
7.
MooreJS, GibsonPR, PerryRE, BurgellRE. Endometriosis in patients with irritable bowel syndrome: Specific symptomatic and demographic profile, and response to the low FODMAP diet. Aust N Z J Obstet Gynaecol, 2017; 57:201–205.
8.
BrownJ, FarquharC. Endometriosis: An overview of Cochrane Reviews. Cochrane Database Syst Rev, 2014:CD009590.
9.
ArmourM, SinclairJ, ChalmersKJ, SmithCA. Self-management strategies amongst Australian women with endometriosis: A national online survey. BMC Complement Altern Med, 2019; 19:17.
10.
MissmerSA, ChavarroJE, MalspeisS, et al.A prospective study of dietary fat consumption and endometriosis risk. Hum Reprod, 2010; 25:1528–1535.
11.
GaibissoT. Is there a universal diet for Endometriosis? 2020. Online document at: https://www.endometriosisaustralia.org/post/is-there-a-universal-diet-for-endometriosis, accessed October6, 2020.
How Tia Mowry learned to use food to ease her endometriosis. 2017. Online document at: https://www.wellandgood.com/good-food/tia-mowry-endometriosis-caused-by-diet-inflammation, accessed January21, 2021.
LeonardiM, HorneAW, VincentK, et al.Self-management strategies to consider to combat endometriosis symptoms during the COVID-19 pandemic. Hum Reprod Open, 2020; 2020:hoaa028.
16.
HarrisHR, ChavarroJE, MalspeisS, et al.Dairy-food, calcium, magnesium, and vitamin D intake and endometriosis: A prospective cohort study. Am J Epidemiol, 2013; 177:420–430.
17.
NodlerJL, HarrisHR, ChavarroJE, et al.Dairy consumption during adolescence and endometriosis risk. Am J Obstet Gynecol, 2020; 222:257 e251–257 e216.
18.
YamamotoA, HarrisHR, VitonisAF, et al.A prospective cohort study of meat and fish consumption and endometriosis risk. Am J Obstet Gynecol, 2018; 219:178 e171–e178 e110.
19.
HeringtonJ, GloreD, LucasJ, et al.Dietary fish oil supplementation inhibits formation of endometriosis—Associated adhesions in a chimeric mouse model. Fertil Steril, 2012; 99.
ChalmersKJ, CatleyMJ, EvansSF, MoseleyGL. Clinical assessment of the impact of pelvic pain on women. Pain, 2017; 158:498–504.
22.
ErlingssonC, BrysiewiczP. A hands-on guide to doing content analysis. Afr J Emerg Med, 2017; 7:93–99.
23.
Vennberg KarlssonJ, PatelH, PrembergA. Experiences of health after dietary changes in endometriosis: A qualitative interview study. BMJ Open, 2020; 10:e032321.
24.
FieldR, PourkazemiF, TurtonJ, RooneyK. Dietary interventions are beneficial for patients with chronic pain: A systematic review with meta-analysis. Pain Med, 2020; 22:694–714.
25.
MarzialiM, VenzaM, LazzaroS, et al.Gluten-free diet: A new strategy for management of painful endometriosis related symptoms?. Minerva Chir, 2012; 67:499–504.
26.
SaidiK, SharmaS, OhlssonB. A systematic review and meta-analysis of the associations between endometriosis and irritable bowel syndrome. Eur J Obstet Gynecol Reprod Biol, 2020; 246:99–105.
27.
SturgeonC, FasanoA. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers, 2016; 4:e1251384.
28.
ShahbazkhaniB, ForootanM, MeratS, et al.Coeliac disease presenting with symptoms of irritable bowel syndrome. Aliment Pharmacol Ther, 2003; 18:231–235.
29.
CatassiC, AlaediniA, BojarskiC, et al.The overlapping area of Non-Celiac Gluten Sensitivity (NCGS) and Wheat-Sensitive Irritable Bowel Syndrome (IBS): An update. Nutrients, 2017; 9:1268.
30.
ChaRR, KimHJ. [Non-celiac Gluten Sensitivity]. Korean J Gastroenterol, 2020; 75:11–16.
31.
SkodjeGI, SarnaVK, MinelleIH, et al.Fructan, rather than gluten, induces symptoms in patients with self-reported non-celiac gluten sensitivity. Gastroenterology, 2018; 154:529–539 e522.
32.
NanayakkaraWS, SkidmorePM, O'BrienL, et al.Efficacy of the low FODMAP diet for treating irritable bowel syndrome: The evidence to date. Clin Exp Gastroenterol, 2016; 9:131–142.
33.
HustoftTN, HauskenT, YstadSO, et al.Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome. Neurogastroenterol Motil, 2017; 29. DOI: 10.1111/nmo.12969.
34.
ZhouSY, Gillilland MIII, WuX, et al.FODMAP diet modulates visceral nociception by lipopolysaccharide-mediated intestinal inflammation and barrier dysfunction. J Clin Invest, 2018; 128:267–280.
35.
KhanKN, FujishitaA, HirakiK, et al.Bacterial contamination hypothesis: A new concept in endometriosis. Reprod Med Biol, 2018; 17:125–133.
36.
StaudacherHM, LomerMC, AndersonJL, et al.Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr, 2012; 142:1510–1518.
37.
StaudacherHM.Nutritional, microbiological and psychosocial implications of the low FODMAP diet. J Gastroenterol Hepatol, 2017; 32Suppl 1:16–19.
38.
ShewryPR, HeySJ. Do we need to worry about eating wheat?. Nutr Bull, 2016; 41:6–13.
39.
van LanenA-S, de BreeA, GreylingA. Efficacy of a low-FODMAP diet in adult irritable bowel syndrome: A systematic review and meta-analysis. Eur J Nutr 2021. [Epub ahead of print]; DOI: 10.1007/s00394-020-02473-0
40.
Ul HaqMR, KapilaR, SharmaR, et al.Comparative evaluation of cow beta-casein variants (A1/A2) consumption on Th2-mediated inflammatory response in mouse gut. Eur J Nutr, 2014; 53:1039–1049.
41.
HeM, SunJ, JiangZQ, YangYX. Effects of cow's milk beta-casein variants on symptoms of milk intolerance in Chinese adults: A multicentre, randomised controlled study. Nutr J, 2017; 16:72.
42.
KurekM, PrzybillaB, HermannK, RingJ. A naturally occurring opioid peptide from cow's milk, beta-casomorphine-7, is a direct histamine releaser in man. Int Arch Allergy Immunol, 1992; 97:115–120.
43.
TheoharidesTC.Neuroendocrinology of mast cells: Challenges and controversies. Exp Dermatol, 2017; 26:751–759.
44.
Munoz-CruzS, Mendoza-RodriguezY, Nava-CastroKE, et al.Gender-related effects of sex steroids on histamine release and FcepsilonRI expression in rat peritoneal mast cells. J Immunol Res, 2015; 2015:351829.
45.
FogelWA.Diamine oxidase (DAO) and female sex hormones. Agents Actions, 1986; 18:44–45.
46.
AnafV, ChapronC, El NakadiI, et al.Pain, mast cells, and nerves in peritoneal, ovarian, and deep infiltrating endometriosis. Fertil Steril, 2006; 86:1336–1343.
47.
HartDA.Targeting mast cells as a viable therapeutic option in endometriosis. EMJ Repro Health, 2017; 3:76–83.
48.
HartDA.Curbing inflammation in multiple sclerosis and endometriosis: Should mast cells be targeted?. Int J Inflam, 2015; 2015:452095.
49.
AfrinLB, DempseyTT, RosenthalLS, DorffSR. Successful mast-cell-targeted treatment of chronic dyspareunia, vaginitis, and dysfunctional uterine bleeding. J Obstet Gynaecol, 2019; 39:664–669.
50.
SharmaSC, SheppardBL, BonnarJ. Uterine mast cell and histamine values in dysfunctional uterine bleeding. Agents Actions, 1993; 38:C281–C282.
51.
RosaAC, FantozziR. The role of histamine in neurogenic inflammation. Br J Pharmacol, 2013; 170:38–45.
52.
CostantiniR, AffaitatiG, WesselmannU, et al.Visceral pain as a triggering factor for fibromyalgia symptoms in comorbid patients. Pain, 2017; 158:1925–1937.
53.
RudzkiL, MaesM. The Microbiota-Gut-Immune-Glia (MGIG) axis in major depression. Mol Neurobiol, 2020; 57:4269–4295.
54.
TolkienK, BradburnS, MurgatroydC. An anti-inflammatory diet as a potential intervention for depressive disorders: A systematic review and meta-analysis. Clin Nutr, 2019; 38:2045–2052.
55.
MoultonCD, PavlidisP, NortonC, et al.Depressive symptoms in inflammatory bowel disease: An extraintestinal manifestation of inflammation?. Clin Exp Immunol, 2019; 197:308–318.
56.
AslamH, RuusunenA, BerkM, et al.Unravelled facets of milk derived opioid peptides: A focus on gut physiology, fractures and obesity. Int J Food Sci Nutr, 2020; 71:36–49.
57.
BellSJ, GrochoskiGT, ClarkeAJ. Health implications of milk containing beta-casein with the A2 genetic variant. Crit Rev Food Sci Nutr, 2006; 46:93–100.
58.
LedochowskiM, WidnerB, BairH, et al.Fructose- and sorbitol-reduced diet improves mood and gastrointestinal disturbances in fructose malabsorbers. Scand J Gastroenterol, 2000; 35:1048–1052.
59.
KortleverTL, Ten Bokkel HuininkS, OffereinsM, et al.Low-FODMAP diet is associated with improved quality of life in IBS patients—A prospective observational study. Nutr Clin Pract, 2019; 34:623–630.
60.
ArmourM, LawsonK, WoodA, et al.The cost of illness and economic burden of endometriosis and chronic pelvic pain in Australia: A national online survey. PLoS One, 2019; 14:e0223316.
61.
ArmourM, SinclairJ, NgCHM, et al.Endometriosis and chronic pelvic pain have similar impact on women, but time to diagnosis is decreasing: An Australian survey. Sci Rep, 2020; 10:16253.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
